Legal status · Canada
Is VK2735 legal in Canada?
No. VK2735 is not approved for any medical use in Canada; its classification is "Investigational, not approved". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Moderate.
VK2735 in Canada at a glance
| Classification | Investigational, not approved |
|---|---|
| Health Canada approval status | Not approved by Health Canada; investigational |
| Evidence level | Moderate (research strength: Moderate) |
| Reviewed | Sep 2026 |
Classification and note come from the VK2735 profile, checked against Health Canada, Health Products and Food Branch (Health Canada) listings at the reviewed date.
What this means
- 01
VK2735 is being studied in registered clinical trials but has not received Health Canada marketing approval in Canada.
- 02
Lawful human access is limited to trial participation or a formal early-access scheme where one exists; there is no pharmacy product to prescribe.
- 03
Vials sold online "for research use only" are not trial material, and that label does not make human use lawful.
What VK2735 is
Viking Therapeutics' dual GLP-1 and GIP agonist in Phase 3 as an injection, with an oral version showing rapid early weight loss.
VK2735 is Viking Therapeutics' dual GLP-1 and GIP receptor agonist, in the same mechanistic class as tirzepatide. 2% at 13 weeks, among the fastest early responses of any oral agent.
Mechanism: Agonizes both the GLP-1 and GIP receptors to enhance insulin secretion, reduce appetite, and slow gastric emptying.
Regulatory history: Investigational (Phase 3 VANQUISH-1 and VANQUISH-2 fully enrolled; oral form completed Phase 2)
How Health Canada treats this kind of product
Authorises drugs for sale through a Notice of Compliance and Drug Identification Number. A compound that is not authorised for sale cannot lawfully be sold for human use, and personal importation of prescription drugs is limited.
The classification above is the The Longevity Archive reading of Health Canada, Health Products and Food Branch listings for VK2735 at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
VK2735 in other countries
Frequently asked questions
Is VK2735 legal in Canada?
No. VK2735 is not approved for any medical use in Canada; its classification is "Investigational, not approved". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Moderate.
Can I buy VK2735 in Canada?
No approved product exists to buy. In Canada VK2735 is classified as "Investigational, not approved", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.
Is VK2735 Health Canada approved?
No. In Canada VK2735 is classified as "Investigational, not approved", which is not a Health Canada marketing approval. For comparison, the US FDA status is: Investigational (Phase 3 VANQUISH-1 and VANQUISH-2 fully enrolled; oral form completed Phase 2). Evidence level: Moderate.
Related compounds in Canada
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for VK2735 live on its compound profile.
VK2735 profileThis page is general information about the regulatory status of VK2735 in Canada, current as of Sep 2026. It is not legal advice, and classifications change; check Health Canada, Health Products and Food Branch directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.